Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 22801 - 22850 of 39437 in total
PDB ID ▼ UniProt ID Title Descriptor
5VOC Q6GMX0 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB Q6SW67 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB Q68674 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB P16837 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB F5HCP3 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB F5HET4 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB S6B291 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB 5VOB Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB S6B291 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB 5VOB Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB Q6GMX0 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB Q6GMX0 Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VNC P27472 Glycogen synthase in complex with UDP and glucosamine
5VN8 B3UEZ6 Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain
5VN8 B3UES2 Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain
5VN8 5VN8 Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain
5VN4 Q57V32 Crystal structure of adenine phosphoribosyl transferase from Trypanosoma brucei in complex with AMP, pyrophosphate, and ribose-5-phosphate
5VN3 B3UEZ6 Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain
5VN3 P01730 Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain
5VN3 B3UES2 Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain
5VN3 5VN3 Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain
5VMJ Q9WFX4 Influenza hemagglutinin H1 mutant DH1E in complex with 3'SLN
5VMJ Q9WFX3 Influenza hemagglutinin H1 mutant DH1E in complex with 3'SLN
5VMG Q9WFX4 Influenza hemagglutinin H1 mutant DH1E in complex with 6'SLN
5VMG Q9WFX3 Influenza hemagglutinin H1 mutant DH1E in complex with 6'SLN
5VMF Q9WFX3 Influenza hemagglutinin H1 mutant DH1D in complex with 6'SLN
5VME Q6MZV7 Crystal structure of human IgG1 Fc K248E, T437R mutant
5VMC Q9WFX3 Influenza hemagglutinin H1 mutant DH1 in complex with 6'SLN
5VMA A8FDC4 Structure of B. pumilus GH48 in complex with a cellobio-derived isofagomine
5VLI P03452 Computationally designed inhibitor peptide HB1.6928.2.3 in complex with influenza hemagglutinin (A/PuertoRico/8/1934)
5VLI 5VLI Computationally designed inhibitor peptide HB1.6928.2.3 in complex with influenza hemagglutinin (A/PuertoRico/8/1934)
5VL3 S6B291 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 5VL3 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 S6B291 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 5VL3 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 Q8TCD0 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 Q8TCD0 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 P20273 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VKS A7YCM0 Crystal structure of P[19] rotavirus VP8* complexed with LNFPI
5VKM P20273 Crystal structure of human CD22 Ig domains 1-3 in complex with alpha 2-6 sialyllactose
5VKJ P20273 Crystal structure of human CD22 Ig domains 1-3
5VKI A7YCM0 Crystal structure of P[19] rotavirus VP8* complexed with mucin core 2
5VK2 P08669 Structural basis for antibody-mediated neutralization of Lassa virus
5VK2 5VK2 Structural basis for antibody-mediated neutralization of Lassa virus
5VJM R4NN21 Crystal structure of H7 hemagglutinin mutant (V186K, K193T, G228S) from the influenza virus A/Shanghai/2/2013 (H7N9) with LSTa
5VJL R4NN21 Crystal structure of H7 hemagglutinin mutant (V186K, K193T, G228S) from the influenza virus A/Shanghai/2/2013 (H7N9) with LSTc
5VJK R4NN21 Crystal structure of H7 hemagglutinin mutant (V186K, K193T, G228S) from the influenza virus A/Shanghai/2/2013 (H7N9)
5VIY Q2N0S6 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY P01834 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY 5VIY BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024